Dongwha Pharm has ranked among the top searched stocks on 6 days within the past month.

As of 9:30 AM on the 12th, Dongwha Pharm is trading at 14,800 KRW, down 2.63% from the previous day. This represents a 52.42% increase compared to May 21. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals such as Gas Hwal Myeong Su and Fusidin.

Over the past 5 days, individual investors have net purchased 97,689 shares, while foreigners and institutions have net sold 13,786 shares and 431 shares, respectively.

On June 5, Dongwha Pharm became a market issue with an 18% rise on news that the COVID-19 treatment was 'animal testing imminent.'

※Source: AI Investment Assistant AI Racciro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing